Apollo Hospitals profit jumps 36% to ₹529 Cr; recommends ₹10 dividend

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
Apollo Hospitals profit jumps 36% to ₹529 Cr; recommends ₹10 dividend
Overview

Apollo Hospitals posted a strong Q4FY26, with revenue rising 18% to ₹6,605 Crore and profit after tax jumping 36% to ₹529 Crore. The company's board also proposed a final dividend of ₹10 per share.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Apollo Hospitals Reports Strong Q4FY26 Results

Apollo Hospitals Enterprise Ltd announced robust financial results for the fourth quarter and full year ended March 31, 2026. Consolidated revenue increased by 18% year-on-year to ₹6,605 Crore, while consolidated profit after tax (PAT) surged by 36% year-on-year to ₹529 Crore.

For the full fiscal year (YTD MAR FY26), consolidated revenue grew 16% year-on-year to ₹25,229 Crore, and PAT rose 34% year-on-year to ₹1,942 Crore.

Dividend and Leadership

The Board of Directors has recommended a final dividend of ₹10 per equity share for FY26, pending shareholder approval at the Annual General Meeting on August 25, 2026. The record date for the dividend is August 14, 2026.

Key leadership updates include the re-appointment of Dr. Prathap C Reddy as Executive Chairman and Ms. Rama Bijapurkar as Independent Director.

Strategic Moves

This strong financial performance is complemented by strategic corporate actions. The company's board approved the merger of its subsidiary, Apollo Hospitals North Ltd, into the parent company. This aims to streamline operations and enhance cost efficiencies.

Furthermore, Apollo has approved the divestiture of stakes in Apollo Specialty Hospitals and Apollo Fertility Centre to Kids Clinic India Limited for approximately ₹1,550 Crore. These entities will no longer be subsidiaries post-transaction, though Apollo Health and Lifestyle Limited will retain a 9.9% stake in the combined Kids Clinic India Limited entity. The transaction is targeted for completion by October 31, 2026.

Outlook and Risks

These strategic moves are contingent on securing necessary regulatory approvals, including from the Competition Commission of India (CCI). Delays in these approvals could affect the execution timeline.

The company is also monitoring the finalization of Labour Codes and is involved in a land dispute with the Karnataka Revenue Department, though it remains optimistic about a favorable resolution.

Apollo Hospitals holds a strong credit rating of AAA/A1+ from ICRA, reflecting its financial stability.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.